AU2003222087B8 - Novel curcumin analogues and uses thereof - Google Patents
Novel curcumin analogues and uses thereof Download PDFInfo
- Publication number
- AU2003222087B8 AU2003222087B8 AU2003222087A AU2003222087A AU2003222087B8 AU 2003222087 B8 AU2003222087 B8 AU 2003222087B8 AU 2003222087 A AU2003222087 A AU 2003222087A AU 2003222087 A AU2003222087 A AU 2003222087A AU 2003222087 B8 AU2003222087 B8 AU 2003222087B8
- Authority
- AU
- Australia
- Prior art keywords
- bonded
- alkoxy
- nitro
- cancer
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/17—Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/172—Saturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
- C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Pregnancy & Childbirth (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008243284A AU2008243284B2 (en) | 2002-04-17 | 2008-11-14 | Novel curcumin analogues and uses thereof |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/124,642 | 2002-04-17 | ||
| US10/124,642 US6790979B2 (en) | 2002-04-17 | 2002-04-17 | Curcumin analogues and uses thereof |
| PCT/US2003/009350 WO2003088927A2 (en) | 2002-04-17 | 2003-03-27 | Novel curcumin analogues and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008243284A Division AU2008243284B2 (en) | 2002-04-17 | 2008-11-14 | Novel curcumin analogues and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2003222087A1 AU2003222087A1 (en) | 2003-11-03 |
| AU2003222087B2 AU2003222087B2 (en) | 2008-08-21 |
| AU2003222087B8 true AU2003222087B8 (en) | 2008-09-04 |
Family
ID=29248380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003222087A Revoked AU2003222087B8 (en) | 2002-04-17 | 2003-03-27 | Novel curcumin analogues and uses thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6790979B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1494993B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5108198B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101025226B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1646473B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE466832T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003222087B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2482002C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60332445D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1494993T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2345930T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04010180A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ535773A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003088927A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7355081B2 (en) * | 2002-04-17 | 2008-04-08 | The University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
| US6790979B2 (en) * | 2002-04-17 | 2004-09-14 | University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
| WO2003105751A2 (en) * | 2002-06-17 | 2003-12-24 | Ho-Jeong Kwon | Novel curcumin derivatives |
| WO2004037269A1 (en) * | 2002-10-23 | 2004-05-06 | Pantarhei Bioscience B.V. | Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| PL1624878T3 (pl) * | 2003-05-22 | 2007-01-31 | Pantarhei Bioscience Bv | Zastosowanie kompozycji zawierającej estrogenowy składnik w celu leczenia i zapobiegania bólowi mięśniowo-szkieletowemu |
| US20050049299A1 (en) * | 2003-08-26 | 2005-03-03 | Aggarwal Bharat B. | Selective inhibitors of stat-3 activation and uses thereof |
| US20080050387A1 (en) * | 2003-12-12 | 2008-02-28 | Chawnshang Chang | Non-Androgen Dependent Roles for Androgen Receptor and Non-Androgen Related Inhibitors of Androgen Receptor |
| CA2554025A1 (en) * | 2004-01-28 | 2005-08-11 | Androscience Corporation | Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof |
| US20060084704A1 (en) * | 2004-01-28 | 2006-04-20 | Charles Shih | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
| US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
| EP1804806A2 (en) * | 2004-09-02 | 2007-07-11 | AndroScience Corporation | Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof |
| WO2006033943A2 (en) * | 2004-09-17 | 2006-03-30 | Exelixis, Inc | Pyrazole kinase modulators and methods of use |
| FR2880276A1 (fr) * | 2005-01-05 | 2006-07-07 | Lefebvre Dominique Caparros | Utilisation des anti-androgenes dans le traitement des comportements agressifs ou impulsifs induits par des maladies du systeme nerveux central |
| EP2023951A4 (en) * | 2006-05-19 | 2010-01-13 | Univ Rochester | PROSTATEEPITHEL ANDROGEN RECEPTOR FOR THE SUPPRESSION OF PROSTATE GROWTH AND TUMORINVASION |
| US7507864B2 (en) * | 2006-08-01 | 2009-03-24 | Salisbury University | Method for the synthesis of curcumin analogues |
| WO2008045534A2 (en) * | 2006-10-12 | 2008-04-17 | Research Foundation Of The City University Of New York | Novel curcumin and tetrahydrocurcumin derivatives |
| US8710272B2 (en) | 2007-01-08 | 2014-04-29 | Androscience Corporation | Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
| DK2104659T3 (en) * | 2007-01-08 | 2015-11-02 | Allianz Pharmascience Ltd | Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof |
| US9000222B2 (en) | 2007-01-08 | 2015-04-07 | Androscience Corporation | Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof |
| CN102432447B (zh) * | 2007-01-22 | 2014-01-08 | 温州医学院生物与天然药物开发中心有限公司 | 含环戊酮的姜黄素单羰基结构类似物及其用途 |
| CN102381951B (zh) * | 2007-01-22 | 2013-09-04 | 温州医学院生物与天然药物开发中心有限公司 | 含环己酮的姜黄素单羰基结构类似物及其用途 |
| CN101003470B (zh) * | 2007-01-22 | 2011-11-02 | 温州医学院生物与天然药物开发中心有限公司 | 姜黄素单羰基结构类似物及其用途 |
| WO2008131059A2 (en) * | 2007-04-17 | 2008-10-30 | Codman & Shurtleff, Inc. | Intranasally administering curcumin in a bolus of helium gas to treat alzheimer's disease |
| US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
| CA2694953C (en) | 2007-07-31 | 2015-12-01 | Androscience Corporation | Compositions including androgen receptor degradation (ard) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| CN101255119B (zh) * | 2008-01-07 | 2014-05-21 | 沈阳药科大学 | 四氢姜黄素衍生物及盐类 |
| US20090282496A1 (en) * | 2008-04-04 | 2009-11-12 | University Of Rochester Medical Center | Androgen Receptor Related Methods for Treating Bladder Cancer |
| CN102046575B (zh) * | 2008-05-30 | 2014-10-29 | 国立大学法人东京工业大学 | 阿尔茨海默病治疗药 |
| CN101434525B (zh) * | 2008-06-05 | 2012-07-04 | 福建医科大学 | 4-(4-羟基-3-甲氧基苯甲基)姜黄素及其用于制备抗肿瘤药物的应用 |
| US7985776B2 (en) * | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
| WO2010033580A2 (en) | 2008-09-19 | 2010-03-25 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Curcumin conjugates for treating and preventing cancers |
| US7723515B1 (en) * | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
| US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
| CN101805285B (zh) * | 2009-02-13 | 2012-02-22 | 南华大学 | 含烟酸姜黄素酯衍生物及其制造方法和用途 |
| ES2761173T3 (es) | 2009-05-15 | 2020-05-19 | Univ New York State Res Found | Análogos de curcumina como quelantes de zinc y sus usos |
| CN101570515B (zh) * | 2009-06-12 | 2011-10-19 | 乐山师范学院 | 姜黄素取代嘧啶类衍生物及其制备方法与用途 |
| CN102091060A (zh) * | 2009-12-10 | 2011-06-15 | 温州医学院 | 治疗或预防糖皮质激素介导的性腺功能减退性功能障碍和/或不育的药物及其应用 |
| US8575221B2 (en) | 2010-03-17 | 2013-11-05 | Concert Pharmaceuticals, Inc. | Derivatives of dimethylcurcumin |
| CN102126938B (zh) * | 2010-12-15 | 2013-03-27 | 厦门大学 | 一种姜黄素类似物及其制备方法和应用 |
| KR101952222B1 (ko) * | 2011-04-11 | 2019-02-26 | 그린 테크 가부시키가이샤 | 신규 피라졸 유도체 |
| EP2782643A1 (en) * | 2011-11-23 | 2014-10-01 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Androgen receptor ligands |
| CN102649750B (zh) * | 2012-04-11 | 2014-01-22 | 福建医科大学 | 姜黄素水杨酰单酯及其合成方法以及其在抗肿瘤、抗炎方面的应用 |
| ES2775173T3 (es) * | 2012-06-18 | 2020-07-24 | Allianz Pharmascience Ltd | Compuestos con armazón estructural de (1E,6E)-1,7-bis-(3,4-dimetoxifenil)-4,4-disustituido-hepa-1,6-dieno-3,5-di-ona, su actividad biológica y usos de los mismos |
| US9220695B2 (en) | 2012-06-29 | 2015-12-29 | The Research Foundation For The State University Of New York | Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances |
| US20160008297A1 (en) * | 2012-08-23 | 2016-01-14 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
| WO2014057772A1 (ja) | 2012-10-10 | 2014-04-17 | 株式会社ファルマエイト | 新規ピラゾール誘導体 |
| CN103159644B (zh) * | 2013-04-08 | 2015-04-15 | 唐山师范学院 | 类姜黄素缩芳香胺希夫碱衍生物及其在制备抗菌药物的应用 |
| CN103222970B (zh) * | 2013-04-10 | 2019-03-26 | 温州医科大学 | 不对称单羰基姜黄素类似物在制备抗肿瘤药物中的应用 |
| CN103254051B (zh) * | 2013-05-28 | 2015-08-12 | 常州大学 | 一种二烷基姜黄素的制备方法 |
| JP6369751B2 (ja) * | 2014-09-05 | 2018-08-08 | 二村 芳弘 | ケラチン産生作用を呈するクルクミン誘導体及びその製造方法 |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US9402834B2 (en) | 2014-10-21 | 2016-08-02 | Ions Pharmaceutical S.À R.L. | Human therapeutic agents |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| CN104557496B (zh) * | 2015-01-21 | 2018-03-16 | 温州医科大学 | 单羰基类化合物、组合物及在制备药物中的应用 |
| WO2018005732A1 (en) | 2016-06-29 | 2018-01-04 | The General Hospital Corporation | Half-curcuminoids as amyloid-beta pet imaging agents |
| US10300000B2 (en) | 2016-09-12 | 2019-05-28 | The Research Foundation For The State University Of New York | Inhibition of melanogenesis by chemically modified curcumins |
| CN106800547B (zh) * | 2017-01-03 | 2019-07-23 | 中国人民解放军第二军医大学 | 一种双取代芳基类化合物及其应用 |
| EP3582747B1 (en) * | 2017-02-15 | 2021-10-13 | Unilever Global IP Limited | A personal care composition |
| CA3062161A1 (en) | 2017-05-01 | 2018-11-08 | Spg Therapeutics, Inc. | Tripartite androgen receptor eliminators, methods and uses thereof |
| CN111315370B (zh) * | 2018-07-28 | 2023-09-29 | 苏州沪云新药研发股份有限公司 | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |
| PL4045071T3 (pl) * | 2019-10-15 | 2026-06-29 | Sami-Sabinsa Group Limited | Kompozycja kurkuminoidów do terpauetycznego postępowania w zespole metanolicznym |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995018606A1 (en) * | 1994-01-06 | 1995-07-13 | Research Development Foundation | Curcumin, analogues of curcumin and novel uses thereof |
| WO1997016403A1 (en) * | 1995-11-03 | 1997-05-09 | Geneprint, Inc. | Process for the synthesis of curcumin-related compounds |
| WO1999022728A1 (en) * | 1997-10-31 | 1999-05-14 | Arch Development Corporation | Methods and compositions for regulation of 5-alpha reductase activity |
| WO2001030335A2 (en) * | 1999-10-22 | 2001-05-03 | The Board Of Trustees Of The University Of Illinois | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07165724A (ja) * | 1993-12-13 | 1995-06-27 | Nkk Corp | ピラゾール誘導体及び血液凝固阻害剤 |
| US5565491A (en) * | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
| JP2000258904A (ja) * | 1999-03-04 | 2000-09-22 | Fujifilm Olin Co Ltd | ネガ型化学増幅系感光性組成物 |
| US6673843B2 (en) * | 1999-06-30 | 2004-01-06 | Emory University | Curcumin and curcuminoid inhibition of angiogenesis |
| AU779230C (en) | 1999-12-03 | 2006-05-25 | Emory University | Curcumin analogues for treating cancer |
| US6790979B2 (en) * | 2002-04-17 | 2004-09-14 | University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
| WO2004052351A1 (en) * | 2002-12-06 | 2004-06-24 | Dsm Ip Assets B.V. | Novel use of lycopene |
| WO2004080396A2 (en) * | 2003-03-07 | 2004-09-23 | The University Of Texas Md Anderson Cancer Center | Liposomal curcumin for treatment of cancer |
-
2002
- 2002-04-17 US US10/124,642 patent/US6790979B2/en not_active Expired - Lifetime
-
2003
- 2003-03-27 JP JP2003585680A patent/JP5108198B2/ja not_active Expired - Fee Related
- 2003-03-27 EP EP03718072A patent/EP1494993B1/en not_active Expired - Lifetime
- 2003-03-27 ES ES03718072T patent/ES2345930T3/es not_active Expired - Lifetime
- 2003-03-27 AT AT03718072T patent/ATE466832T1/de not_active IP Right Cessation
- 2003-03-27 MX MXPA04010180A patent/MXPA04010180A/es active IP Right Grant
- 2003-03-27 AU AU2003222087A patent/AU2003222087B8/en not_active Revoked
- 2003-03-27 DE DE60332445T patent/DE60332445D1/de not_active Expired - Lifetime
- 2003-03-27 NZ NZ535773A patent/NZ535773A/en not_active IP Right Cessation
- 2003-03-27 WO PCT/US2003/009350 patent/WO2003088927A2/en not_active Ceased
- 2003-03-27 KR KR1020097018211A patent/KR101025226B1/ko not_active Expired - Fee Related
- 2003-03-27 KR KR1020047016357A patent/KR100984512B1/ko not_active Expired - Fee Related
- 2003-03-27 CN CN038086506A patent/CN1646473B/zh not_active Expired - Fee Related
- 2003-03-27 CA CA2482002A patent/CA2482002C/en not_active Expired - Lifetime
- 2003-03-27 DK DK03718072.6T patent/DK1494993T3/da active
-
2010
- 2010-01-25 JP JP2010012930A patent/JP2010150266A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995018606A1 (en) * | 1994-01-06 | 1995-07-13 | Research Development Foundation | Curcumin, analogues of curcumin and novel uses thereof |
| WO1997016403A1 (en) * | 1995-11-03 | 1997-05-09 | Geneprint, Inc. | Process for the synthesis of curcumin-related compounds |
| WO1999022728A1 (en) * | 1997-10-31 | 1999-05-14 | Arch Development Corporation | Methods and compositions for regulation of 5-alpha reductase activity |
| WO2001030335A2 (en) * | 1999-10-22 | 2001-05-03 | The Board Of Trustees Of The University Of Illinois | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease |
Non-Patent Citations (10)
| Title |
|---|
| (RESEARCH DEVELOPMENT FOUNDATION) 13 July 1995 * |
| ANTO R. J. ET AL., International Journal of Pharmaceutics, vol. 131, pages 1-7 (1996) * |
| BERZIN V. B. ET AL., Bioorganicheskaya Khimiya, vol. 22, no. 10-11, pages 823-831 (1996) * |
| CA 128:110377 * |
| CHOWDHURY H. ET AL., Pest Manag. Sci., vol. 56, pages 1086-1092 (2000) * |
| MASUDA T. ET AL., Phytochemistry, vol. 31, no. 10, pages 3645-3647 (1992) * |
| NURFINA A. N. ET AL., Eur. J. Med. Chem., vol. 32, pages 321-328 (1997) * |
| PARVEEN I. ET AL., J. Labelled Cpd. Radiopharm., vol. 43, pages 883-889 (2000) * |
| PEDERSEN U. ET AL., Liebigs Ann. Chem., vol. 8, pages 1557-1569 (1985) * |
| TRUSTEES OF THE UNIVERSITY OF ILLINOIS) 3 May 2001 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1646473B (zh) | 2010-10-13 |
| CN1646473A (zh) | 2005-07-27 |
| DE60332445D1 (de) | 2010-06-17 |
| KR20050009989A (ko) | 2005-01-26 |
| JP2010150266A (ja) | 2010-07-08 |
| ATE466832T1 (de) | 2010-05-15 |
| DK1494993T3 (da) | 2010-08-23 |
| WO2003088927A3 (en) | 2004-04-01 |
| NZ535773A (en) | 2007-01-26 |
| KR100984512B1 (ko) | 2010-09-30 |
| WO2003088927A2 (en) | 2003-10-30 |
| MXPA04010180A (es) | 2005-02-03 |
| US20030203933A1 (en) | 2003-10-30 |
| JP2005534626A (ja) | 2005-11-17 |
| KR101025226B1 (ko) | 2011-04-01 |
| EP1494993A2 (en) | 2005-01-12 |
| HK1078846A1 (en) | 2006-03-24 |
| KR20090132590A (ko) | 2009-12-30 |
| ES2345930T3 (es) | 2010-10-06 |
| US6790979B2 (en) | 2004-09-14 |
| CA2482002A1 (en) | 2003-10-30 |
| EP1494993B1 (en) | 2010-05-05 |
| AU2003222087B2 (en) | 2008-08-21 |
| CA2482002C (en) | 2012-07-17 |
| JP5108198B2 (ja) | 2012-12-26 |
| AU2003222087A1 (en) | 2003-11-03 |
| EP1494993A4 (en) | 2005-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003222087B2 (en) | Novel curcumin analogues and uses thereof | |
| US7709535B2 (en) | Curcumin analogues and uses thereof | |
| JP2016518394A (ja) | アンドロゲン受容体調節薬のエステル誘導体およびそれらの使用のための方法 | |
| US6713510B2 (en) | 6-Methoxy-2-naphthylacetic acid prodrugs | |
| CN110325508B (zh) | 雄激素受体的n-末端结构域的抑制剂 | |
| AU2008243284B2 (en) | Novel curcumin analogues and uses thereof | |
| CA2387098A1 (en) | 6-methoxy-2-naphthylacetic acid prodrugs compositions for treating inflammation | |
| HK1078846B (en) | Novel curcumin analogues and uses thereof | |
| HK40015967A (zh) | 雄激素受体的n-末端结构域的抑制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH | Corrigenda |
Free format text: IN VOL 22, NO 33, PAGE(S) 3966 UNDER THE HEADING APPLICATIONS ACCEPTED -NAME INDEX UNDER THE NAME UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, APPLICATION NO. 2003222087, UNDER INID (72), CORRECT THE CO-INVENTOR NAME TO READ SHIH, CHARLES, C Y |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MAK | Offer to surrender letters patent |